Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents and therapeutics to allow for expanded use of curative hematopoietic stem cell transplants and gene therapies.
--(BUSINESS WIRE)-- Jasper Therapeutics is a biotechnology company focused on enabling safer conditioning agents and therapeutics to allow for expanded use of curative hematopoietic stem cell transplants and gene therapies. Jasper Therapeutics’ lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant. For more information, please visit us at www.jaspertherapeutics.com.
| Company: | Jasper Therapeutics, Inc | |
| Headquarters Address: | 3000 Sand Hill Road B1-145 | |
| Menlo Park, CA | ||
| Main Telephone: | 1-650-254-6687 | |
| Website: | ||
| Type of Organization: | Private | |
| Industry: | Biotechnology | |
| Key Executives: | Executive Chairman and Interim Chief Executive Officer: William Lis | |
| Chief Business Officer, Chief Financial Officer: Jeet Mahal | ||
| Company Contact | ||
| Contact: | Jeet Mahal | |
| Phone: | 1-650-254-6687 | |
| Email: | ||
| Public Relations | ||
| Contact: | Julie Normart | |
| Phone: | 1-415-946-1087 | |
| Email: |
View source version on businesswire.com: https://www.businesswire.com/news/home/20191208005053/en/
Source: Jasper Therapeutics, Inc
View this news release online at:
http://www.businesswire.com/news/home/20191208005053/en
